BEIJING, Nov. 9, 2025 /PRNewswire/ -- A news report from China Daily: In October, the ancestral home of Mazu on Meizhou Island, Fujian province, welcomed 30 youth delegates from around the world. Hailing from locations as diverse as Madagascar, France, Kenya, Malaysia, and Russia, they embarked on a journey to trace the origins and cultural influence of Mazu, the Goddess of the Sea. The delegati...
BEIJING, Nov. 9, 2025 /PRNewswire/ -- A news report from China Daily: In October, the ancestral home of Mazu on Meizhou Island, Fujian province, welcomed 30 youth delegates from around the world. Hailing from locations as diverse as Madagascar, France, Kenya, Malaysia, and Russia, they embarked on a journey to trace the origins and cultural influence of Mazu, the Goddess of the Sea. The delegati...
HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("MediTrust Health") signed a strategic cooperation agreement. The two parties will carry out in-depth cooperation around innovative drugs and comm...
HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("MediTrust Health") signed a strategic cooperation agreement. The two parties will carry out in-depth cooperation around innovative drugs and comm...
NEW ORLEANS, Nov. 10, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, a long-acting Apolipoprotein C3 (ApoC3) siRNA. RN0361 achieved potent, durable reductions in ApoC3 and triglycerides (TG) lasting at least six months in a single dose first-in-human trial, establishing a potential b...
NEW ORLEANS, Nov. 10, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, presented highlights of Phase 1 clinical data for RN0361, a long-acting Apolipoprotein C3 (ApoC3) siRNA. RN0361 achieved potent, durable reductions in ApoC3 and triglycerides (TG) lasting at least six months in a single dose first-in-human trial, establishing a potential b...
SINGAPORE, Nov. 10, 2025 /PRNewswire/ -- Following two highly successful years as the premier retail event for retail leaders, innovators and solutions providers across Asia Pacific, NRF 2026: Retail's Big Show Asia Pacific is returning to Singapore on June 2-4, 2026, bringing together more than 11,000 retail professionals from 80 countries for three days of transformat...
SINGAPORE, Nov. 10, 2025 /PRNewswire/ -- Following two highly successful years as the premier retail event for retail leaders, innovators and solutions providers across Asia Pacific, NRF 2026: Retail's Big Show Asia Pacific is returning to Singapore on June 2-4, 2026, bringing together more than 11,000 retail professionals from 80 countries for three days of transformat...
SINGAPORE, Nov. 10, 2025 /PRNewswire/ -- Alarm.com (Nasdaq: ALRM), the leading platform for intelligently connected properties, will demonstrate its unified smart security ecosystem at The Security Event Asia 2025, showing how the company helps organizations bridge legacy systems with modern, cloud-managed technology. The showcase marks a significant step in Alarm.com's cont...
SINGAPORE, Nov. 10, 2025 /PRNewswire/ -- Alarm.com (Nasdaq: ALRM), the leading platform for intelligently connected properties, will demonstrate its unified smart security ecosystem at The Security Event Asia 2025, showing how the company helps organizations bridge legacy systems with modern, cloud-managed technology. The showcase marks a significant step in Alarm.com's cont...
Disclaimer: We are a tourism service provider that provides room booking services for The Mandala Hotel We are not the official website of the hotel, please be aware.